D.A. Davidson & CO. Sells 1,176 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

D.A. Davidson & CO. cut its position in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 15.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,345 shares of the financial services provider’s stock after selling 1,176 shares during the quarter. D.A. Davidson & CO.’s holdings in iShares Biotechnology ETF were worth $776,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Glass Jacobson Investment Advisors llc boosted its position in iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 122 shares during the period. PCA Investment Advisory Services Inc. bought a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at $28,000. CoreFirst Bank & Trust purchased a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth about $30,000. Horizon Bancorp Inc. IN purchased a new position in iShares Biotechnology ETF in the 3rd quarter worth about $44,000. Finally, Archer Investment Corp bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $48,000. 69.61% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $135.76 on Tuesday. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $139.49. The business has a 50 day simple moving average of $133.90 and a two-hundred day simple moving average of $126.69.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 27th. Investors of record on Thursday, December 21st were issued a dividend of $0.124 per share. The ex-dividend date of this dividend was Wednesday, December 20th. This represents a $0.50 annualized dividend and a yield of 0.37%.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Stories

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.